The effect of herbal syrup on patients with corona

Evaluation of the effect of herbal oral product (thyme syrup) in patients with COVID-19

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20131129015584N2

Enrollment

152

Registered

2020-05-08

Start date

2020-04-04

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS. Acute respiratory distress syndrome

Interventions

Intervention 1: Intervention group: standard treatment of COVID-19 + herbal syrup (Iranian medicine product made by the research team): 100 cc of the syrup is mixed with 100 cc of hot water and eaten

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Probable diagnosis of COVID-19 based on national Iranian protocol

Exclusion criteria

Exclusion criteria: Late 5 days from the onset of symptoms Existence of comorbidity Pregnancy and lactation history of Allergy Complicated with bacterial infection

Design outcomes

Primary

Measure	Time frame
Blood oxygen saturation level. Timepoint: 0,1,2,3,5,7 days after intervention. Method of measurement: Pulse oximetry.	—

Secondary

Measure	Time frame
Degree of dyspnea. Timepoint: 0,1,2,3,5,7 days after intervention. Method of measurement: Likert,s scale.;Duration of hospital stay. Timepoint: 7days after intervention. Method of measurement: day.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAssie Jokar

Mazandaran University of Medical Sciences

a-jokar@razi.tums.ac.ir+98 11 3324 3117

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026